AB Science S.A.

Symbol: AB.PA




Market price today

  • -6.0017

    P/E Ratio

  • -1.5604

    PEG Ratio

  • 119.00M

    MRK Cap

  • 0.00%

    DIV Yield

AB Science S.A. (AB-PA) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO:Mr. Alain Moussy MBA
Full-time employees:89
Address:3, Avenue George V

AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company also develops AB8939, synthetic microtubule destabilizer for the treatment of acute myeloid leukemia; and AB20001, which is in Phase 2 clinical trial to evaluate the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients with moderate and severe COVID-19. It markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.

General Outlook

In simple terms, AB Science S.A. has 55.866 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep -0.972% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -25.568%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -21.731%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.509% return, is a testament to AB Science S.A.'s adeptness in optimizing resource deployment. AB Science S.A.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.615%. Furthermore, the proficiency of AB Science S.A. in capital utilization is underscored by a remarkable -1.681% return on capital employed.

Stock Prices

AB Science S.A.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $2.39, while its low point bottomed out at $2.04. This variance in figures offers investors a lucid insight into the roller-coaster ride that is AB Science S.A.'s stock market.

Liquidity Ratios

Analyzing AB.PA liquidity ratios reveals its financial health of the firm. The current ratio of 143.01% gauges short-term asset coverage for liabilities. The quick ratio (141.30%) assesses immediate liquidity, while the cash ratio (69.15%) indicates cash reserves.

Current Ratio143.01%
Quick Ratio141.30%
Cash Ratio69.15%

Profitability Ratios

AB.PA profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -2771.30% underscores its earnings before tax deductions. The effective tax rate stands at 21.59%, revealing its tax efficiency. The net income per EBT, 78.41%, and the EBT per EBIT, 108.39%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -2556.76%, we grasp its operational profitability.

Pretax Profit Margin-2771.30%
Effective Tax Rate21.59%
Net Income per EBT78.41%
EBT per EBIT108.39%
EBIT per Revenue-2556.76%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.43, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 5.04% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

Days of Sales Outstanding141
Days of Inventory Outstanding96
Operating Cycle7342.22
Days of Payables Outstanding1786
Cash Conversion Cycle5556
Receivables Turnover0.05
Payables Turnover0.20
Inventory Turnover3.81
Fixed Asset Turnover0.82
Asset Turnover0.02

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.38, and free cash flow per share, -0.38, depict cash generation on a per-share basis. The cash per share value, 0.31, showcases liquidity position. Lastly, the operating cash flow sales ratio, -23.28, offers insight into cash flow relative to sales.

Operating Cash Flow per Share-0.38
Free Cash Flow per Share-0.38
Cash per Share0.31
Operating Cash Flow Sales Ratio-23.28
Free Cash Flow to Operating Cash Flow Ratio1.00
Cash Flow Coverage Ratio-0.93
Short Term Coverage Ratio-8.64
Capital Expenditure Coverage Ratio-296.51
Dividend Paid and Capex Coverage Ratio-296.51

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 58.34%, highlights its total liabilities relative to assets. With a debt-equity ratio of -1.01, we discern the balance between debt and equity financing. The long-term debt to capitalization, -885.39%, and total debt to capitalization, 13544.06%, ratios shed light on its capital structure. An interest coverage of -9.51 indicates its ability to manage interest expenses.

Debt Ratio58.34%
Debt Equity Ratio-1.01
Long Term Debt to Capitalization-885.39%
Total Debt to Capitalization13544.06%
Interest Coverage-9.51
Cash Flow to Debt Ratio-0.93
Company Equity Multiplier-1.73

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.02, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.22, reflects the portion of profit attributed to each share. The book value per share, -0.56, represents the net asset value distributed per share, while the tangible book value per share, -0.59, excludes intangible assets.

Revenue Per Share0.02
Net Income Per Share-0.22
Book Value Per Share-0.56
Tangible Book Value Per Share-0.59
Shareholders Equity Per Share-0.56
Interest Debt Per Share0.41
Capex Per Share-0.01

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -40.39%, indicates top-line expansion, while the gross profit growth, -38.03%, reveals profitability trends. EBIT growth, -15.43%, and operating income growth, -15.43%, offer insights into operational profitability progression.

Revenue Growth-40.39%
Gross Profit Growth-38.03%
EBIT Growth-15.43%
Operating Income Growth-15.43%
Net Income Growth5.86%
Weighted Average Shares Growth-3.19%
Weighted Average Shares Diluted Growth-3.19%
Operating Cash Flow Growth-1.71%
Free Cash Flow Growth-2.10%
10-Year Revenue Growth per Share-63.54%
5-Year Revenue Growth per Share-68.60%
3-Year Revenue Growth per Share-61.95%
10-Year Operating CF Growth per Share-43.46%
5-Year Operating CF Growth per Share56.51%
3-Year Operating CF Growth per Share28.07%
10-Year Net Income Growth per Share36.79%
5-Year Net Income Growth per Share71.39%
3-Year Net Income Growth per Share60.94%
10-Year Shareholders Equity Growth per Share-471.33%
5-Year Shareholders Equity Growth per Share-289.38%
3-Year Shareholders Equity Growth per Share17.04%
Receivables Growth49.81%
Inventory Growth223.40%
Asset Growth12.08%
Book Value per Share Growth-58.84%
Debt Growth186.84%
R&D Expense Growth18.80%
SGA Expenses Growth-47.06%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 464,353,152.4, captures the company's total value, considering both debt and equity. Income quality, 1.28, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 1.95, gauges operational efficiency, while the research and development to revenue, 1393.01%, highlights investment in innovation. The ratio of intangibles to total assets, 6.82%, indicates the value of non-physical assets, and capex to operating cash flow, 3.69%, measures reinvestment capability.

Enterprise Value464,353,152.4
Income Quality1.28
Sales General and Administrative to Revenue1.95
Research and Development to Revenue1393.01%
Intangibles to Total Assets6.82%
Capex to Operating Cash Flow3.69%
Capex to Revenue-67.22%
Capex to Depreciation795.06%
Stock-Based Compensation to Revenue13.88%
Graham Number1.66
Return on Tangible Assets-61.29%
Graham Net Net-0.68
Working Capital-2,207,000
Tangible Asset Value-37,296,000
Net Current Asset Value-38,639,000
Invested Capital-1
Average Receivables10,436,000
Average Payables9,365,000
Average Inventory298,500
Days Sales Outstanding4769
Days Payables Outstanding86682
Days of Inventory On Hand5369

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, -5.27, and the price to book ratio, -5.27, reflect the market's valuation relative to the company's book value. The price to sales ratio, 153.15, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -6.60, and price to operating cash flows, -5.60, gauge market valuation against cash flow metrics.

Price Book Value Ratio-5.27
Price to Book Ratio-5.27
Price to Sales Ratio153.15
Price Cash Flow Ratio-5.60
Price Earnings to Growth Ratio-1.56
Enterprise Value Multiple-6.26
Price Fair Value-5.27
Price to Operating Cash Flow Ratio-5.60
Price to Free Cash Flows Ratio-6.60
Price to Tangible Book Ratio-12.55
Enterprise Value to Sales484.71
Enterprise Value Over EBITDA-40.05
EV to Operating Cash Flow-26.58
Earnings Yield-3.04%
Free Cash Flow Yield-4.05%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of AB Science S.A. (AB.PA) on the EURONEXT in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -6.002 in 2024.

What is the ticker symbol of AB Science S.A. stock?

The ticker symbol of AB Science S.A. stock is AB.PA.

What is company IPO date?

IPO date of AB Science S.A. is 2010-04-26.

What is company current share price?

Current share price is 2.130 EUR.

What is stock market cap today?

The market cap of stock today is 118995592.000.

What is PEG ratio in 2024?

The current -1.560 is -1.560 in 2024.

What is the number of employees in 2024?

In 2024 the company has 89.